NCT07119398

Brief Summary

Data on the optimal mode of labor induction after preterm prelabor rupture of membranes (PPROM) is lacking. Studies have shown no difference between oxytocin and misoprostol use for labor induction in this cohort (1). The preponderance of evidence from term pregnancies suggests that Foley catheter coupled with oxytocin is better than oxytocin alone, with a higher rate of delivery within 24 hours when a Foley catheter followed by oxytocin is compared to oxytocin alone. However, the use of a Foley catheter has not been evaluated in prospective studies on patients with PPROM.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for phase_4

Timeline
8mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Jul 2025Dec 2026

Study Start

First participant enrolled

July 14, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

July 21, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

August 13, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

1 year

First QC Date

July 21, 2025

Last Update Submit

August 5, 2025

Conditions

Keywords

InductionPPROMPreterm prelabor rupture of membranes

Outcome Measures

Primary Outcomes (1)

  • Vaginal Delivery within 12 Hours

    Vaginal Delivery within 12 hours of induction

    12 hours

Secondary Outcomes (19)

  • Vaginal Delivery Rate

    From enrollment until delivery

  • Intraamniotic Infection

    Enrollment through 6 weeks postpartum

  • Operative vaginal delivery

    From enrollment until delivery

  • Cesarean delivery

    From enrollment until delivery

  • Estimated and quantitative blood loss

    From enrollment until hospital discharge (up to 5 days post-delivery).

  • +14 more secondary outcomes

Study Arms (2)

Oxytocin plus Foley

EXPERIMENTAL

• Induction of labor with intravenous oxytocin and a transcervical Foley catheter

Combination Product: Oxytocin plus Foley Catheter

Oxytocin Only

ACTIVE COMPARATOR

• Induction of labor with intravenous oxytocin

Drug: Oxytocin

Interventions

Oxytocin plus Foley CatheterCOMBINATION_PRODUCT

Intravenous oxytocin and a transcervical Foley catheter

Oxytocin plus Foley

Intravenous oxytocin

Oxytocin Only

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients 18-50 years of age;
  • The patient is fluent in English, physically and mentally able to understand the informed consent, and is willing to participate in this study;
  • PPROM;
  • Cervical dilation \</= 2cm
  • Fetal cephalic presentation;
  • The patient is between 34 weeks 0 days and 36 weeks 6 days of gestation at the time of enrollment. Gestational age will be determined by last menstrual period, confirmed with a first trimester ultrasound, per the recommended guidelines by the American College of Obstetricians and Gynecologists.

You may not qualify if:

  • Spontaneous labor
  • Known allergy to latex;
  • Cervical dilation \>2cm;
  • Chorioamnionitis;
  • Contraindications to induction of labor or use of Foley for cervical ripening
  • HIV
  • Known or suspected fetal anomaly or aneuploidy;
  • Prisoners.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sentara Norfolk General Hospital

Norfolk, Virginia, 23507, United States

RECRUITING

Related Publications (7)

  • McMaster K, Sanchez-Ramos L, Kaunitz AM. Evaluation of a Transcervical Foley Catheter as a Source of Infection: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015 Sep;126(3):539-551. doi: 10.1097/AOG.0000000000001002.

    PMID: 26244535BACKGROUND
  • Gomez Slagle HB, Hoffman MK, Sciscione AC, Ma'ayeh M. Combination Foley Catheter-Oxytocin versus Oxytocin Alone following Preterm Premature Rupture of Membranes. Am J Perinatol. 2024 May;41(S 01):e3030-e3034. doi: 10.1055/a-2185-4102. Epub 2023 Oct 4.

    PMID: 37793430BACKGROUND
  • Amorosa JMH, Stone J, Factor SH, Booker W, Newland M, Bianco A. A randomized trial of Foley Bulb for Labor Induction in Premature Rupture of Membranes in Nulliparas (FLIP). Am J Obstet Gynecol. 2017 Sep;217(3):360.e1-360.e7. doi: 10.1016/j.ajog.2017.04.038. Epub 2017 May 4.

    PMID: 28479288BACKGROUND
  • Mackeen AD, Durie DE, Lin M, Huls CK, Qureshey E, Paglia MJ, Sun H, Sciscione A. Foley Plus Oxytocin Compared With Oxytocin for Induction After Membrane Rupture: A Randomized Controlled Trial. Obstet Gynecol. 2018 Jan;131(1):4-11. doi: 10.1097/AOG.0000000000002374.

    PMID: 29215519BACKGROUND
  • Levine LD, Downes KL, Elovitz MA, Parry S, Sammel MD, Srinivas SK. Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial. Obstet Gynecol. 2016 Dec;128(6):1357-1364. doi: 10.1097/AOG.0000000000001778.

    PMID: 27824758BACKGROUND
  • Schoen CN, Grant G, Berghella V, Hoffman MK, Sciscione A. Intracervical Foley Catheter With and Without Oxytocin for Labor Induction: A Randomized Controlled Trial. Obstet Gynecol. 2017 Jun;129(6):1046-1053. doi: 10.1097/AOG.0000000000002032.

    PMID: 28486381BACKGROUND
  • Lin MG, Nuthalapaty FS, Carver AR, Case AS, Ramsey PS. Misoprostol for labor induction in women with term premature rupture of membranes: a meta-analysis. Obstet Gynecol. 2005 Sep;106(3):593-601. doi: 10.1097/01.AOG.0000172425.56840.57.

    PMID: 16135593BACKGROUND

MeSH Terms

Conditions

Fetal Membranes, Premature RupturePreterm Premature Rupture of the Membranes

Interventions

Oxytocin

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Pituitary Hormones, PosteriorPituitary HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and Proteins

Study Officials

  • Marwan Ma'ayeh, MD

    Eastern Virginia Medical School

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kristin Ayers, MPH

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is a non-blinded prospective randomized pilot trial of pregnant patients with a singleton pregnancy between 34 weeks 0 days and 36 weeks 6 days gestation with PPROM receiving an induction of labor. Participants will be randomized to either: * Induction of labor with intravenous oxytocin * Induction of labor with intravenous oxytocin and a transcervical Foley catheter
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 21, 2025

First Posted

August 13, 2025

Study Start

July 14, 2025

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

August 13, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations